RBC starts Lexeo at outperform, cites Friedreich’s ataxia drug opportunity (NASDAQ:LXEO)
second illustrations and pictures/iStock through Getty Photographs RBC Capital Markets has initiated protection of newly public Lexeo Therapeutics (NASDAQ:LXEO) with ...